ArticleAging2023

Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic biomarker in pancreatic cancer.

Qian Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.